197 related articles for article (PubMed ID: 18762337)
1. Favorable outcome with chemo-immunotherapy in Burkitt lymphoma and leukemia.
Griskevicius L; Stulpinas R; Vengalyte I; Saulyte-Trakymiene S; Mickys U; Pranys D; Kurtinaitis J; Jurgutis M
Leuk Res; 2009 Apr; 33(4):587-8. PubMed ID: 18762337
[No Abstract] [Full Text] [Related]
2. Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia.
Todeschini G; Bonifacio M; Tecchio C; Balter R; Carli G; Stefani PM; Adami F; Zamò A; Dei Tos AP; Marino F; Gherlinzoni F; Marradi P; Semenzato G; Pizzolo G
Am J Hematol; 2012 Jan; 87(1):22-5. PubMed ID: 22086870
[TBL] [Abstract][Full Text] [Related]
3. A case of relapsed meningeal Burkitt's leukemia/lymphoma treated with intraventricular rituximab combined with high-dose cytarabine.
Billio A; Svaldi M; Morello E; Amato B; Coser P
Am J Hematol; 2006 Oct; 81(10):798-9. PubMed ID: 16838326
[No Abstract] [Full Text] [Related]
4. Rituximab in a child with relapsed Burkitt lymphoma.
Bay A; Dogan M; Acikgoz M; Oner AF
Pediatr Blood Cancer; 2007 Aug; 49(2):218. PubMed ID: 16847929
[No Abstract] [Full Text] [Related]
5. Burkitt's lymphoma-- what is new?
Abinya ON
East Afr Med J; 2008 May; 85(5):205-6. PubMed ID: 18814529
[No Abstract] [Full Text] [Related]
6. [Therapeutic results in Burkitt's lymphoma].
López J; Melero C; Montalbán MA; García-Muñoz F; Nazario G; Valverde F; Gil C; Bernacer M; Aracil J; Contra T
An Esp Pediatr; 1988 Oct; 29 Suppl 34():141-4. PubMed ID: 3214024
[No Abstract] [Full Text] [Related]
7. Absent immunoglobulins in HIV-related Burkitt lymphoma/leukaemia.
Shimomura A; Lilienfeld-Toal Mv; Balta Z; Schroers E; Schmidt-Wolf IG; Büttner R; Rücker Av; Gütgemann I
Ann Hematol; 2008 Mar; 87(3):255-6. PubMed ID: 17917728
[No Abstract] [Full Text] [Related]
8. Endemic Burkitt lymphoma of maxillofacial region: results of induction treatment with cyclophosphamide plus methotrexate in West Africa.
Béogo R; Nacro B; Ouédraogo D; Ouoba K
Pediatr Blood Cancer; 2011 Jul; 56(7):1068-70. PubMed ID: 21344617
[TBL] [Abstract][Full Text] [Related]
9. [Non-Hodgkin lymphomas of the Burkitt type].
Herrero Díez A; Lamamie de Clairac P; Muro Brussi M; Meana Meana A; Donoro Mazario M
An Esp Pediatr; 1988 Oct; 29 Suppl 34():112-3. PubMed ID: 3214015
[No Abstract] [Full Text] [Related]
10. Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome.
Choi KA; Lee JE; Kim YG; Kim DJ; Kim K; Ko YH; Oh HY; Kim WS; Huh W
Ann Hematol; 2009 Jul; 88(7):639-45. PubMed ID: 19030857
[TBL] [Abstract][Full Text] [Related]
11. Liposomal cytarabine in cerebrospinal fluid.
Boyd K; Jenner M; Treleaven J; Kenny J; Rhoades E
Br J Haematol; 2009 Jun; 145(6):679. PubMed ID: 19076172
[No Abstract] [Full Text] [Related]
12. High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients.
Oriol A; Ribera JM; Bergua J; Giménez Mesa E; Grande C; Esteve J; Brunet S; Moreno MJ; Escoda L; Hernandez-Rivas JM; Hoelzer D
Cancer; 2008 Jul; 113(1):117-25. PubMed ID: 18457327
[TBL] [Abstract][Full Text] [Related]
13. Addition of rituximab to high-dose methotrexate-based chemotherapy improves survival of adults with Burkitt lymphoma/leukemia.
Dujmovic D; Aurer I; Radman I; Serventi-Seiwerth R; Dotlic S; Stern-Padovan R; Dubravcic K; Santek F; Labar B
Acta Haematol; 2012; 127(2):115-7. PubMed ID: 22212303
[No Abstract] [Full Text] [Related]
14. [Maxillofacial location of Burkitt lymphoma at the University Hospital Center of Ouagadougou, Burkina Faso].
Ouoba K; Dao M; Sakande B; Kabre M; Cisse R; Sanou A
Med Trop (Mars); 1997; 57(4):415-6. PubMed ID: 9612790
[No Abstract] [Full Text] [Related]
15. Severe central nervous adverse effect of intrathecal chemotherapy in a 16-yr-old patient with Burkitt's type lymphoma.
Geissler RG; Bergmann L; Hacker H; Knupp B; Walker B; Hoelzer D
Eur J Haematol; 1997 Apr; 58(4):286-8. PubMed ID: 9186541
[No Abstract] [Full Text] [Related]
16. Long-term survival of patients with Burkitt's lymphoma: an assessment of treatment and other factors which may relate to survival.
Clifford P; Singh S; Stjernswärd J; Klein G
Cancer Res; 1967 Dec; 27(12):2578-615. PubMed ID: 6082297
[No Abstract] [Full Text] [Related]
17. [Sub-cutaneous location of Burkitt's lymphoma. Apropos of 1 case at Yopougon Central University Hospital, Abidjan (Côte d'Ivoire)].
Adonis-Koffy L; Koffi G; Sawadogo D; Timité-Konan AM; Sangaré A; Boka M
Bull Soc Pathol Exot; 2003 May; 96(2):90-1. PubMed ID: 12836522
[TBL] [Abstract][Full Text] [Related]
18. Burkitt-like post-transplant lymphoproliferative disorder (PTLD) presenting with breast mass in a renal transplant recipient: a report of a rare case.
Law MF; Chan HN; Leung C; Lai HK; Ha CY; Ng C; Yeung YM; Yip SF
Ann Hematol; 2014 Dec; 93(12):2083-5. PubMed ID: 24782123
[No Abstract] [Full Text] [Related]
19. Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine.
Inamdar KV; Romaguera JE; Drakos E; Knoblock RJ; Garcia M; Leventaki V; Medeiros LJ; Rassidakis GZ
Cancer; 2009 Oct; 115(20):4727-36. PubMed ID: 19708031
[TBL] [Abstract][Full Text] [Related]
20. [Burkitt's lymphoma in Tunisia. Apropos of 18 cases].
Ben Ayed F; Boussen H; Jaafoura M; Ben Youssef R; Marouene A; Trabelsi N; Tabbane F; Cammoun M; Mourali N
Tunis Med; 1984; 62(1):73-7. PubMed ID: 6528380
[No Abstract] [Full Text] [Related]
[Next] [New Search]
